Opaleye Management Inc. Gossamer Bio, Inc. Transaction History

Opaleye Management Inc.

$600 Million
Q3 2025

A detailed history of Opaleye Management Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 2,725,000 shares of GOSS stock, worth $7.38 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

2,725,000

Previous 3,545,000 23.13%

Holding current value

$7.38 Million

Previous $4.36 Million 64.36%

% of portfolio

1.19%

Previous 1.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.21 - $3.46 $992,200 - $2.84 Million	-820,000 Reduced 23.13%	2,725,000 $7.17 Million
Q2 2025 Aug 14, 2025	SELL	$0.78 - $1.44 $579,083 - $1.07 Million	-742,415 Reduced 17.32%	3,545,000 $4.36 Million
Q1 2025 May 15, 2025	SELL	$0.85 - $1.53 $172,197 - $309,955	-202,585 Reduced 4.51%	4,287,415 $4.72 Million
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $544,493 - $882,739	824,990 Added 22.51%	4,490,000 $4.04 Million
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $193,542 - $306,237	-244,990 Reduced 6.27%	3,665,010 $3.63 Million
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $749,644 - $1.87 Million	1,469,891 Added 60.24%	3,910,000 $3.52 Million
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $433,672 - $818,557	-542,091 Reduced 18.18%	2,440,109 $2.88 Million
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $850,560 - $1.91 Million	-1,772,000 Reduced 37.27%	2,982,200 $2.71 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $1.08 Million - $2.52 Million	1,384,200 Added 41.07%	4,754,200 $3.95 Million
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.53 $3.3 Million - $5.16 Million	3,370,000 New	3,370,000 $4.04 Million

Others Institutions Holding GOSS

# of Institutions

179

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Gossamer Bio, Inc. Transaction History